FSMAX
Price
$115.66
Change
+$1.23 (+1.07%)
Updated
Jun 2 closing price
Net Assets
42.73B
LCLAX
Price
$60.59
Change
-$0.12 (-0.20%)
Updated
Jun 2 closing price
Net Assets
3.37B
Interact to see
Advertisement

FSMAX vs LCLAX

Header iconFSMAX vs LCLAX Comparison
Open Charts FSMAX vs LCLAXBanner chart's image
FSMAX vs LCLAX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. LCLAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a StrongBuy and LCLAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 42.7B vs. LCLAX (3.37B). FSMAX pays higher dividends than LCLAX: FSMAX (0.50) vs LCLAX (0.00). FSMAX was incepted earlier than LCLAX: FSMAX (15 years) vs LCLAX (13 years). LCLAX (1.39) is less costly to investors than FSMAX (0.04). LCLAX is a more actively managed with annual turnover of: 29.00 vs. FSMAX (23.00). FSMAX has a lower initial minimum investment than LCLAX: FSMAX (0) vs LCLAX (1000). FSMAX annual gain was more profitable for investors over the last year : 30.08 vs. LCLAX (14.98). FSMAX return over 5 years is better than : 37.47 vs. LCLAX (19.81).
FSMAXLCLAXFSMAX / LCLAX
Total Expense Ratio0.041.343%
Annual Report Gross Expense Ratio0.041.393%
Fund Existence15 years13 years-
Gain YTD14.8905.528269%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets42.7B3.37B1,267%
Annual Yield % from dividends0.500.00-
Returns for 1 year30.0814.98201%
Returns for 3 years73.3851.10144%
Returns for 5 years37.4719.81189%
Returns for 10 years143.95329.0544%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RIGGX50.46N/A
N/A
American Funds Intl Gr and Inc R6
CMUAX17.28N/A
N/A
Columbia Select Mid Cap Value A
GPGIX3.89N/A
N/A
Grandeur Peak Global Opportunities Instl
CIGYX11.41N/A
N/A
AB International Growth Advisor
HFDRX21.05N/A
N/A
Hartford Schroders US MidCap Opps R3